Table 2.
Correlations between BCAAs and cardiometabolic risk factors.
| Variables | BCAAs | L-Leu | L-Ile | L-Val |
|---|---|---|---|---|
| Age | 0.083 | 0.079 | 0.070 | 0.066 |
| Ln (waist circumference) | 0.219∗ | 0.215∗ | 0.212∗ | 0.176∗ |
| BMI | 0.169∗ | 0.148∗ | 0.145∗ | 0.160∗ |
| SBP | −0.002 | −0.014 | −0.012 | 0.02 |
| DBP | −0.032 | −0.033 | −0.025 | −0.021 |
| Ln (FPG) | 0.260∗ | 0.215∗ | 0.216∗ | 0.249∗ |
| HbA1c | 0.164∗ | 0.125∗ | 0.139∗ | 0.181∗ |
| TC | 0.005 | 0.007 | 0.04 | 0.032 |
| Ln (TG) | 0.264∗ | 0.234∗ | 0.230∗ | 0.240∗ |
| Ln (HDL-C) | −0.268∗ | −0.255∗ | −0.281∗ | −0.206∗ |
| LDL-C | 0.017 | 0.050 | 0.032 | −0.016 |
| UA | 0.213∗ | 0.217∗ | 0.221∗ | 0.154∗ |
| eGFR | −0.062 | −0.089 | −0.079 | 0.033 |
| MS components | 0.223∗ | 0.194∗ | 0.203∗ | 0.197∗ |
| CVD risk score | 0.204∗ | 0.198∗ | 0.240∗ | 0.144∗ |
Notes. ∗ P < 0.01. Data that were not normally distributed were Napierian logarithmically transformed before analysis. BCAAs: branched-chain amino acids; MS: metabolic system; CVD: cardiovascular disease; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; FPG: fasting plasma glucose; HbA1c: hemoglobin A1c; TG: triglycerides; TC: total cholesterol; UA: uric acid; e-GFR: estimated glomerular filtration rate; L-Leu: L-leucine; L-Ile: L-isoleucine; and L-Val: L-valine.